Aditum Bio
Biotechnology ResearchView the employees at
Aditum Bio-
Jeffrey Blumenstein CMC Development and Manufacturing
-
New York, New York, United States
-
Top 5%
Chris Daige, MS, DABT Senior Director, Nonclinical Development at Aditum Bio-
Austin, Texas Metropolitan Area
-
Rising Star
Kristen Signs Director Clinical Operations - Aditum Bio-
Clarksville, Texas, United States
-
Rising Star
Shyanne Ali Aditum Bio-
New York City Metropolitan Area
-
Rising Star
Maura Pagano Director of Human Resources-
Seattle, Washington, United States
-
Rising Star
Overview
Aditum is the Latin word for "access," and our mission is to give patients access to medicines that may not otherwise be developed. Aditum Bio is a new model of biotech venture capital uniquely positioned to rapidly translate scientific discoveries into innovative new medicines. Aditum Bio brings together unmatched scientific and domain expertise, combined with operational capabilities. Our agile operating model enables rapid company formation, planning and execution for a new model of drug development . We target clinic-ready therapies to help underserved patient populations, rapidly forming companies and staffing them with medical and scientific experts. Launched in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research, Dr. Mark Fishman, Aditum Bio currently manages a broad portfolio of clinical stage companies. For more information, please visit www.aditumbio.com.
-